Pharmacogenomics studies how a person’s genes affect their response to medicines. The U.S. Food and Drug Administration (FDA) has found over 400 connections between drugs and genes. This shows pharmacogenomics is important for healthcare. By using this genetic information, doctors can pick medicines that work better and cause fewer side effects for each patient.
Even though pharmacogenomics is useful, many doctors find it hard to use. A 2021 survey showed 78% of doctors wanted to use pharmacogenomics but were not confident in reading genetic test results for prescribing medicine. This lack of confidence often happens because genetic data in electronic health records (EHRs) and clinical decision support (CDS) systems is hard to understand.
For healthcare leaders in the U.S., it is important to understand these problems and find ways to fix them in order to use pharmacogenomics well in patient care.
Pharmacogenomic information is complicated. Test results often show gene types or traits that need special training to understand. Many EHR systems do not show this data clearly or fit it easily into a doctor’s usual work.
Doctors need pharmacogenomic data that is clear, useful, and fits into their daily work to help patients safely.
Clinical Decision Support (CDS) systems help doctors make decisions at the point of care. For pharmacogenomics, CDS can explain complex genetic data and turn it into clear advice on medicine choices. There are two main types of CDS:
Both types are important for using pharmacogenomics well. Passive CDS lets doctors check results when they want. Active CDS makes sure they do not miss important genetic advice while prescribing.
The Clinical Pharmacogenetics Implementation Consortium (CPIC) helps by offering guidelines that clearly explain gene-drug recommendations. CPIC’s work allows these guidelines to be easily added to EHR systems.
A study by the National Institutes of Health (NIH) led by Joan Kapusnik-Uner, PharmD, looked at how to make pharmacogenomic decision support easier to use. The study created a system called “PillHarmonics.” It combined genetic alerts with other medication alerts, like drug-drug or drug-allergy warnings. Doctors tested the system in practice-like situations and mostly gave positive feedback.
Key findings were:
This study showed that just having genetic tests in the EHR is not enough. The data must be easy to understand and useful.
Several tools help make pharmacogenomic data easier to use:
These tools lower the difficulty doctors face and support safer medication choices for patients.
Artificial Intelligence (AI) and automation help present and use pharmacogenomic data better in clinics.
AI-Powered Data Interpretation: AI can quickly study complex genetic data and explain gene-drug links more accurately than people. It learns from many examples and gives updated, personalized advice, reducing mistakes.
Automated Alerts & Reminders: AI-driven systems find when a prescribed drug might not work well with a patient’s genes. Then, alerts tell the doctor about the problem and suggest dose changes or other drugs, right inside the EHR, when they need it.
Streamlined Clinical Workflows: Automation cuts down on manual searching for genetic info or checking many rules. It lets doctors focus on care. The system can also suggest genetic testing if data is missing, helping make medicine more precise.
Continuous Knowledge Updates: AI scans new medical studies and rules to keep decision support advice current as science changes.
For U.S. medical leaders, adding AI and automation into pharmacogenomic systems means better workflow and easier, clearer data for doctors. It also lowers alert overload by giving the most important warnings first.
Setting up pharmacogenomic decision support in U.S. clinics needs attention to several points:
By planning well, clinics can add user-friendly pharmacogenomic tools that help patients without too much strain on budgets or staff.
Clear, simple, and timely pharmacogenomic decision support improves patient care in many ways:
These benefits support U.S. healthcare goals to improve quality, safety, and patient-centered care.
People in charge of clinical work and technology in U.S. clinics have an important job in helping pharmacogenomics become common:
By doing these things, clinic leaders can make pharmacogenomics a useful part of everyday healthcare.
The purpose is to utilize clinical decision support (CDS) to address implementation challenges, streamline pharmacotherapy, and improve patient care by providing clinicians with relevant pharmacogenomic information at the point of care.
CDS provides point-of-care guidance that helps clinicians use pharmacogenomics effectively, ensuring that individual patient genetic profiles are considered when making medication decisions.
Important considerations include clinical workflows, identification of alert triggers, and tools for interpreting results to ensure seamless integration into EHR.
Passive CDS delivers information without direct clinician intervention, while active CDS prompts clinicians with alerts or recommendations, enhancing their decision-making process.
Challenges include the growing volume of pharmacogenomic knowledge, enduring test results, and the complexity of interpreting this data within clinical workflows.
CPIC provides resources and recommendations that help clinicians integrate pharmacogenomic data and support the interpretation of gene-drug interactions in clinical practice.
Precision medicine leverages individual genetic information, including pharmacogenomics, to tailor treatment strategies, optimizing drug efficacy and reducing adverse effects.
Integrating ancillary systems outside the EHR can augment its capabilities, providing additional support for interpreting pharmacogenomic data and improving clinical decision-making.
Effective pharmacogenomic CDS can lead to improved medication safety, reduced adverse drug reactions, and better therapeutic outcomes through personalized treatment plans.
Recommendations related to gene-drug pairs should be summarized and provided in a user-friendly manner that integrates seamlessly into the clinician’s existing workflow.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
